|
Name |
(5S,7R)-5,7,9,10-tetrahydroxy-2-methoxy-7-methyl-6,8-dihydro-5H-anthracene-1,4-dione
|
Molecular Formula | C16H16O7 | |
IUPAC Name* |
(5S,7R)-5,7,9,10-tetrahydroxy-2-methoxy-7-methyl-6,8-dihydro-5H-anthracene-1,4-dione
|
|
SMILES |
C[C@@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C=C(C3=O)OC)O)O)O
|
|
InChI |
InChI=1S/C16H16O7/c1-16(22)4-6-10(8(18)5-16)15(21)11-7(17)3-9(23-2)14(20)12(11)13(6)19/h3,8,18-19,21-22H,4-5H2,1-2H3/t8-,16+/m0/s1
|
|
InChIKey |
WWTHHBSODPGTAK-ZKANADHPSA-N
|
|
Synonyms |
(1S,3R)-Austrocorbtirubin; (5S,7R)-5,7,9,10-tetrahydroxy-2-methoxy-7-methyl-6,8-dihydro-5H-anthracene-1,4-dione
|
|
CAS | NA | |
PubChem CID | 10495914 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 320.29 | ALogp: | 1.1 |
HBD: | 4 | HBA: | 7 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 124.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 23 | QED Weighted: | 0.572 |
Caco-2 Permeability: | -5.433 | MDCK Permeability: | 0.00000573 |
Pgp-inhibitor: | 0.027 | Pgp-substrate: | 0.142 |
Human Intestinal Absorption (HIA): | 0.836 | 20% Bioavailability (F20%): | 0.058 |
30% Bioavailability (F30%): | 0.82 |
Blood-Brain-Barrier Penetration (BBB): | 0.007 | Plasma Protein Binding (PPB): | 95.39% |
Volume Distribution (VD): | 0.968 | Fu: | 9.19% |
CYP1A2-inhibitor: | 0.583 | CYP1A2-substrate: | 0.899 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.062 |
CYP2C9-inhibitor: | 0.36 | CYP2C9-substrate: | 0.619 |
CYP2D6-inhibitor: | 0.087 | CYP2D6-substrate: | 0.197 |
CYP3A4-inhibitor: | 0.088 | CYP3A4-substrate: | 0.108 |
Clearance (CL): | 9.245 | Half-life (T1/2): | 0.668 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.049 |
Drug-inuced Liver Injury (DILI): | 0.86 | AMES Toxicity: | 0.547 |
Rat Oral Acute Toxicity: | 0.024 | Maximum Recommended Daily Dose: | 0.292 |
Skin Sensitization: | 0.875 | Carcinogencity: | 0.038 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.567 |
Respiratory Toxicity: | 0.292 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002308 | 0.690 | D01XWG | 0.367 | ||||
ENC000709 | 0.644 | D01XDL | 0.359 | ||||
ENC003733 | 0.595 | D07VLY | 0.358 | ||||
ENC005095 | 0.577 | D0C9XJ | 0.358 | ||||
ENC006087 | 0.577 | D0T5XN | 0.306 | ||||
ENC005119 | 0.573 | D0T8EH | 0.301 | ||||
ENC003536 | 0.544 | D07IPB | 0.284 | ||||
ENC005208 | 0.538 | D0R9WP | 0.250 | ||||
ENC000925 | 0.532 | D08LTU | 0.244 | ||||
ENC005342 | 0.506 | D08NQZ | 0.239 |